Transcatheter Aortic Valve Replacement Market Scope And Analysis

Report Code : TIPRE00018508
Category : Life Sciences

No. of Pages : 150

Buy Now

Transcatheter Aortic Valve Replacement Market Scope and Key Players Analysis by 2031

Buy Now

Transcatheter Aortic Valve Replacement Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 6.34 Billion
Market Size by 2031	US$ 19.63 Billion
Global CAGR (2023 - 2031)	15.2%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Procedure Transfemoral Implantation Transapical Implantation Transaortic Implantation By Material Stainless Steel Nitinol Cobalt Chromium By Mechanism Balloon-Expanding Valve and Self-Expanding Valve By End User Hospitals Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories Medtronic Plc Artivion Inc Boston Scientific Corp Edwards Lifesciences Corp JenaValve Technology Inc Blue Sail Medical Co Ltd JC Medical Inc Venus Medtech HangZhou Inc Anteris Technologies Ltd

Regional Analysis

Based on geography, the market is primarily segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, North America held the largest transcatheter aortic valve replacement market share in 2023. The US dominates the market in this region owing to the increasing cases of cardiac diseases and the growing number of product launches by key players.

Industry Developments and Future Opportunities:

The transcatheter aortic valve replacement market forecast can help stakeholders in this marketplace plan their growth strategies. As per company press releases, a few strategic developments by leading players operating in the global market are listed below:

In December 2022, Abbott launched the Navitor TAVI system to treat aortic stenosis cases in India. This latest-generation TAVI system offers best-in-class deliverability and access through small vessels. The system, with its advanced features, helps reduce or eliminate the risk of blood leakage around the valve implant, ultimately expanding treatment options for patients with severe aortic stenosis.
In September 2022, Medtronic the launch of Evolut FX next-generation TAVR system in the US for the treatment of symptomatic severe aortic stenosis. This self-expanding system significantly improved commissure alignment during TAVR procedures compared to earlier-generation Evolut systems.

Abbott Laboratories; Medtronic Plc.; Artivion Inc; Boston Scientific Corp; Edwards Lifesciences Corp; JenaValve Technology, Inc.; Blue Sail Medical Co Ltd; JC Medical, Inc; Venus Medtech HangZhou Inc; and Anteris Technologies Ltd are a few of the key companies profiled in the transcatheter aortic valve replacement market report. These leading players focus on expanding and diversifying their market presence and clientele, tapping business opportunities in the market.